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Abstract
Background: Although there is a call for patient-centred prenatal care, women’s preferences for and concerns
about preterm birth (PTB) prevention have not been well-studied. Therefore, we conducted a cross-sectional survey
to determine women’s preferences for PTB prevention and their likelihood of following their healthcare provider’s
recommendations for PTB prevention, as well as factors associated with these responses.
Methods: A piloted self-administered questionnaire was completed by pregnant women who could read English.
Data were collected about their preferences for and concerns about PTB prevention, and the likelihood of following
their healthcare provider’s recommendations, using multivariable logistic regression to control for other factors.
Results: Three hundred and eleven women at a median of 32-weeks of gestation completed the survey, a response
rate of 85.2%. Most women reported that if they were told they were at increased risk for PTB, they preferred not to
use PTB prevention (65.8%), of whom almost all (93.4%) reported they preferred close-monitoring and 6.6% preferred
neither monitoring nor prevention. A much smaller proportion of women reported that they would not follow their
healthcare provider’s recommendation for progesterone (10.9%) compared to pessary (28.7%) or cerclage (50.2%).
Women who were neither married nor in a common-law relationship were more likely to report that they would not
follow recommendations for progesterone (aOR = 5.88 [95% CI: 1.72, 20.00]). Most women (84.5%) reported they would
use other sources of information other than their main healthcare provider to learn more about PTB prevention, with
the most popular source being the internet.
Conclusions: Most women reported that if they were told they were at increased risk of PTB, they preferred close-
monitoring over using PTB prevention. Their reported likelihood of not following their healthcare provider’s
recommendations for PTB prevention varied from 10.9% for progesterone to 50.2% for cerclage. These findings suggest
that more education about the risk of PTB, PTB preventions, as well as compliance with progesterone is needed and
that the internet would be an important source of information. However as our study was completed by women at a
median of 32 weeks of gestation, future surveys targeted at women earlier in their pregnancy are needed.
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Background
Preterm birth (PTB) is a serious public health concern.
It is the leading cause of perinatal mortality in Canada
[1] and is also associated with an increased risk of neo-
natal death [2]. Beyond its contribution to mortality,
PTB can have lifelong effects on neurodevelopmental
functioning through cerebral palsy, impaired learning,
and visual disorders [3]. The maternal psychological cost
is also high as many women experience anxiety and
stress over the immediate and long-term health conse-
quences for their preterm infant [4].
Interventions to reduce the risk for PTB include pro-
gesterone [5], cerclage [6, 7], and pessary [8]. Most of
these studies have been conducted in women with a
short cervix and/or a previous spontaneous PTB [5–7].
Furthermore, to date, studies have not found one pre-
vention to be most effective in reducing PTB risk [9, 10].
The uncertainty over the best prevention is reflected in
guidelines which note the limited evidence to support
progesterone [11] and cerclage uses [12]. In the absence
of clear guidelines, the decision to use PTB prevention is
mostly left up to women and their healthcare providers.
Given that 56.2% of women who eventually have PTB do
not have traditional PTB risk factors [13], studying the
acceptability of PTB prevention and identifying prefer-
ences and concerns that can be addressed during coun-
selling is important.
Moreover, although there is a call for patient-centred
prenatal care [14], women’s preferences for and concerns
about PTB prevention have not been well-studied. A
previous cross-sectional survey [15] and two chart re-
view studies [16, 17] focused on the acceptability of and
concerns about progesterone. We identified one health-
care provider survey on cerclage [18], but most studies
have focused on counselling practices on progesterone
[15, 18–24]. The need to consider women’s preferences
is important because evidence has shown that most
women reported greater satisfaction with their preg-
nancy when they were actively involved in medical deci-
sions [25], and satisfaction, in turn, has been linked to
increased confidence in their ability to take better care
of themselves and their infants [26]. Despite this import-
ance, there has been no study to date conducted in
women to understand their preferences for and concerns
about PTB prevention overall.
To help address this important gap, we designed a sur-
vey, informed by previous studies [15] to understand
women’s preferences for and concerns about PTB pre-
vention including progesterone, cerclage, and pessary.
Methods
The design of our survey followed Dillman’s Method
[27] and the reporting of results was informed by Kelley
et al. [28].
Recruitment
The study sample included women from obstetric clinics
and midwifery clinics in Southwestern Ontario, Canada.
Between November 2015 and February 2016, clinic staff
mentioned the survey to all potentially eligible women.
Interested women were referred to research personnel
(V.H.), who described the purpose of the survey and dis-
tributed the hard copies of the questionnaire. Consent to
participate was indicated by completion and submission
of the questionnaire. The Hamilton Health Sciences/
McMaster University granted Research Ethics Board ap-
proval for study prior to commencement (Reference
Number: 2015-0459-GRA).
Eligibility Criteria
Pregnant women who could read English sufficiently
well were eligible to participate. Because greater than
56.2% of women who experience PTB do not present
with traditional risk factors [13], we included all
women, not only those identified as having increased
risk of PTB.
Questionnaire
To inform the design of our questionnaire, the first to
our knowledge, to study women’s preferences for and
concerns about PTB prevention including progesterone,
cerclage, and pessary, three electronic databases (MED-
LINE, EMBASE, and CINAHL) were searched up until
April 2015 to identify previous surveys on PTB preven-
tion. One previous survey that used an invalidated ques-
tionnaire to ask women about their preferences for
progesterone therapy was identified [15]. We used the
findings of this previous study to inform the develop-
ment of our questionnaire.
Our questionnaire gathered information on: 1) socio-
demographics, 2) past and current pregnancies, 3) pref-
erences for and concerns about each of the three PTB
preventions, 4) likelihood of following their healthcare
provider’s recommendation for each of the PTB preven-
tions and 5) sources of information that women would
seek to learn more about PTB prevention (see Add-
itional File 1). Questions were a mix of five-point Likert
scales, open-ended, and semi-closed ended questions.
The questionnaire was piloted for comprehensibility of
questions and answers and for flow in three women of
child-bearing age and was revised accordingly.
Outcomes
Our primary outcome was the preference not to use
PTB prevention if women were told they were at in-
creased risk for PTB. Secondary outcomes included the
proportion of women who reported they would not fol-
low their healthcare provider’s recommendation for PTB
prevention and associated factors.
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Sample size calculation
To provide a precise estimate for our primary outcome,
we used a one proportion calculation formula to deter-
mine our sample size: n = p (1-p) (1.96/m)2, where n is
the sample size, p is the estimated proportion, and m is
the margin of error. Because we were unsure of the pro-
portion of women who would prefer any PTB preven-
tion, we assumed that p = 0.50. For this estimated
proportion, we found that the formula provided the lar-
gest sample size when m = 0.06. Thus, we conservatively
estimated that we needed to recruit 310 respondents for
our survey with a missing data rate of 15%.
Statistical Analysis
Responses from completed questionnaires were entered
into LimeSurvey (Version 1.91+ Build 120302) for data
management. Data were analyzed using SAS 9.4 (SAS Insti-
tute Inc, Cary, North Carolina). Normally distributed con-
tinuous variables were calculated as means with standard
deviations (SD) and non-normally distributed continuous
variables were calculated as medians with their interquartile
ranges (IQR). Categorical variables were described as
counts and percentages. Continuous variables were tested
for significance using the independent t-test or Mann–
Whitney-Wilcoxon test and categorical variables were
tested using Fisher’s Exact or chi-squared tests. A threshold
of p ≤ 0.05 was used to determine statistical significance.
Multivariable logistic regression was conducted for our
primary and secondary outcomes, and the results are re-
ported as adjusted odds ratios (aOR) with 95% confi-
dence intervals (CIs). To select variables for our
multivariable logistic regression, we considered a priori
biologically plausible variables performed with a p-value
for entry in a stepwise regression set at 0.10 and p-value
for stay set at 0.20. A priori chosen variables included
age, ethnicity, education, relationship status, type of
healthcare provider whom women selected for prenatal
care, smoking status, PTB risk status for the current
pregnancy, gestational week at the time the question-
naire was completed, concerns about PTB preventions,
and in the case of the secondary outcome, preference to
not use PTB prevention. Multicollinearity was assessed
using variance inflation factor (VIF), where a VIF less
than or equal to five was considered to be evidence of
multicollinearity. If multicollinearity was detected, the
variable with the most biological plausibility was kept or
if biological plausibility between variables were consid-
ered equal, the variable with the greater number of re-
sponses was kept. Only participants who provided a
response to every question in the questionnaire was in-
cluded in the multivariable logistic model for analysis
(i.e. complete-case analysis).
For our primary outcome, women were asked to “im-
agine a scenario in which their healthcare provider
thought they were at increased risk of premature or early
birth” and then to indicate which of the following types
of management they would prefer. Based on their re-
sponses, we grouped women who responded with a pref-
erence for one or more of the three PTB preventions
(progesterone, cerclage, pessary) as having a “preference
to use prevention” while women who responded with a
preference for close-monitoring only or preference for
no prevention at all as having a “preference to not use
prevention.” For our secondary outcome, women were
asked to indicate “how likely or unlikely they would be
to follow their healthcare provider’s recommendation if
their main healthcare provider had recommended the
following preventions?” Taking a similar approach as our
primary outcome, women who reported that they were
“not likely” or “slightly unlikely” to follow healthcare
provider’s recommendation on a 5-point Likert scale
were categorized as those who “reported they would not
follow the recommendation” and women who reported
that they were “neutral,” “slightly likely,” or “extremely




Of the 365 pregnant women who were eligible, 311
women completed the survey, a response rate of 85.2%.
One woman was excluded as she had had >50% incom-
plete data. The average missing data rate per question
was 1.4%.
Characteristics of survey respondents
Respondents had a mean age of 30.9 years and self-
identified predominantly as European/White-Caucasian
(82.1%, Table 1). Most women were married or in a
common-law relationship (94.5%), and had received at
least some post-secondary education (84.5%). A small
proportion currently smoked (7.4%). The median gesta-
tional age at the time the questionnaire was completed
was 32.0 weeks (IQR: 26.7- 35.7 weeks). Most women
had had a previous pregnancy (61.5%), of whom 25
(13.2%) reported that they had had a PTB. Thirteen
(4.2%) pregnant women have been told by their health-
care provider that their current pregnancy was at in-
creased risk for PTB, of whom 10 had received a
cervical assessment by ultrasound only (76.9%), one re-
ceived a cervical assessment by ultrasound and proges-
terone (7.7%), one was instructed to do light physical
activity (7.7%), and one did not report receiving an ultra-
sound or advice (7.7%). Respondents reported receiving
most of their prenatal care from obstetricians (44.4%),
midwives (33.8%), and family doctors (17.4%).
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Preference for PTB prevention
Most women (65.8%) reported that if their healthcare
provider told them they were at increased risk for PTB,
they would prefer not to use any prevention; of whom
185 (93.4%) women preferred close-monitoring only and
13 (6.6%) women preferred no prevention at all includ-
ing close-monitoring (Table 2). Of those who did report
a preference for prevention, 53 (60.2%) women reported
they preferred to use one type of prevention to manage
their PTB risk and 25 (24.3%) women reported they pre-
ferred to use all three preventions. Progesterone was the
most frequently chosen choice amongst women who
preferred to use one type of prevention (84.9%) and
amongst women who preferred to use two preventions
(94.4%). Our univariate and multivariate logistic regres-
sion did not identify any significant factors associated
with a preference to not use PTB prevention.
Almost all women rated concerns about effectiveness
of the three preventions or the potential harm caused by
them to the infant or themselves as “slightly important”
or “extremely important”, on a Likert scale ranging from
“extremely unimportant” to “extremely important”
(Table 3). In contrast, the cost of progesterone was not
viewed as being of high importance to most women.
Likelihood of following healthcare provider’s
recommendation for PTB prevention
The highest proportion of women reported they would
not follow their healthcare provider’s recommendation
was for cerclage (50.2%), followed by pessary (28.7%)
and then progesterone (10.9%). (Table 4)
Women who were not married or in a common-law
relationship were significantly more likely to report they
would not follow recommendations for progesterone
(aOR = 5.88 [95% CIs: 1.72, 20.00]; p = 0.0049, Table 5)
than women who are married or in a common-law rela-
tionship. In addition, women who preferred not to use
prevention were more likely to report they would not
follow recommendations for cerclage (aOR = 3.39 [95%
CI: 1.93, 5.96]; p < 0.0001) or pessary (aOR = 2.99 [95%
CI: 1.51, 5.92]; p = 0.002).
Sources of information on PTB prevention
Two hundred sixty-two women (84.5%) reported they
would use other sources of information other than their
main healthcare provider to help them make their deci-
sions to use PTB prevention. The top four information
sources that women reported they would use were the
internet (70.9%), family and friends (55.5%), other
healthcare providers (40.0%), and books or scientific lit-
erature (38.1%).
Discussion
This was the first survey to our knowledge conducted to
study the preferences for and concerns about current
options for preterm prevention in pregnant women.
Most women reported that they preferred not to use
prevention but preferred close-monitoring of their preg-
nancy if they were told by their healthcare provider they
were at increased risk for PTB. Approximately 50.2%
and 28.7% of women reported that they would not fol-
low their healthcare provider’s recommendations for
cerclage and pessary, respectively, but only 10.9% did for
progesterone. These findings were surprising because we
had hypothesized that pessary would be more attractive
than progesterone to many women and since previous
surveys have reported a high acceptance rate for PTB
prevention with progesterone among women who had
been identified to be at increased risk of PTB [15–17].
There are a few reasons which might explain why
most women preferred not to use prevention if they had
been told by their healthcare provider they were at in-
creased risk of PTB. Although it may relate to the hypo-
thetical nature of the scenario, it may also reflect
respondents’ lack of understanding about the risks of
preterm birth, which points to important opportunities





Age (years), mean ± SD 30.9 (5.4)
Gestational age (weeks), median (interquartile range) 32.0 (26.7,
35.7)
European/White-Caucasian (self-reported) 252 (82.1)
Married or in a common-law relationship 292 (94.5)
Education
Secondary school or less 48 (15.5)
Post-secondary school 262 (84.5)
Current smokers 23 (7.4)
Obstetric History
Prior miscarriage 28 (14.7)
Prior full-term birth (≥37 weeks) 150 (48.5)
Prior preterm birth (<37 weeks) 25 (13.2)
Received progesterone 2 (8.0)
Advised to rest in bed (bedrest) 1 (4.0)
Current Pregnancy Characteristics
First-time pregnancy 119 (38.5)
Told by healthcare provider that they were at increased
risk for preterm birth
13 (4.2)
Received ultrasound 10 (76.9)
Received ultrasound + progesterone 1 (7.7)
aN = 311 respondents completed the survey
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Table 2 Comparison of the characteristics between women who preferred no prevention vs women who preferred at least one
prevention






Age (years), mean ± SD 30.7 (5.6) 31.0 (5.1) 0.64
European or White-Caucasian ethnicity (self-reported) 167 (85.6) 90 (88.2) 0.59
Post-secondary education 164 (82.8) 90 (87.4) 0.32
Married or in common-law relationship 185 (93.9) 99 (96.1) 0.59
Current Smokers 14 (7.1) 8 (7.8) 0.82
Primary Healthcare Provider
Obstetrician 87 (43.9) 49 (47.1) 0.42
Family physician 62 (31.3) 37 (35.6)
Midwife 40 (20.2) 13 (12.5)
Otherse 9 (4.6) 5 (4.8)
Obstetric History
Prior full-term birth 95 (79.8) 51 (76.1) 0.58
Prior preterm birth 14 (11.8) 11 (16.2) 0.50
Prior use of preterm birth prevention 2 (14.3) 1 (9.1) 1.00
Received progesterone 0 (0.0) 1 (50.0) 1.00
Advised to rest in bed (bedrest) 1 (100.0) 1 (50.0) 1.00
Current Pregnancy Characteristics
Gestational age at point of survey completion (weeks), mean ± SDf 31.0 (7.6) 29.6 (7.5) 0.12
At increased risk for preterm birth 12 (6.1) 1 (1.0) 0.04
Preterm Birth Prevention Preferences
Preferred no close-monitoring nor prevention 13 (6.6)
Preferred close-monitoring only 185 (93.4)
Preferred close-monitoring and prevention 15 (14.6)
Preferred progesterone only 13 (86.7)
Preferred cerclage only 1 (6.7)
Preferred all 3 preventions 1 (6.7)
Preferred preterm birth prevention only 88 (85.4)
Selected 1 prevention only 53 (60.2)
Progesterone only 45 (84.9)
Cerclage only 5 (9.4)
Pessary only 3 (5.7)
Selected 2 preventions 18 (20.4)
Progesterone + Cerclage 8 (44.4)
Progesterone + Pessary 9 (50.0)
Cerclage + Pessary 1 (5.6)
Selected all 3 preventions 25 (24.3)
aData is expressed as n (%) unless otherwise specified
b“Preferred no prevention” included women who preferred no prevention, close-monitoring only, or were not using a prevention if they were at increased risk for
preterm birth
c“Preferred prevention” included women who preferred a prevention, close-monitoring and a prevention, or were using a prevention if they were at increased risk
for preterm birth
dSignificance was assessed using independent t-test for continuous variables and chi-squared test or Fisher’s exact test for categorical variables;
eOthers included Maternal-Foetal Medicine Specialists, Nurses, and Fertility Specialists
fMann-Whitney-Wilcoxon test was used to test for significance
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for education. Alternatively, healthcare providers’ satis-
faction with their knowledge and confidence in the qual-
ity of evidence for progesterone have been associated
with its prescription [24]. Interestingly, patient charac-
teristics do not consistently elicit its prescription, even
for women visiting the same clinic [14, 24]. Other stud-
ies also reported that there is significant variation in
clinical practice in progesterone for PTB prevention
even amongst those working in the same clinic serving
women with high-risk pregnancies [14, 16–18]. However,
two surveys found that most healthcare providers would
be willing to take part in hypothetical progesterone trials
to further evaluate its effects on PTB prevention [21,
29]. Taken together these studies suggest that the behav-
iour of healthcare providers may play an important role
in women’s decision to use PTB prevention and health-
care provider’s preferences for and concerns about PTB
prevention need to be studied to better understand how
their thought processes may influence their clinical
practice.
The reluctance to follow recommendations for preven-
tions that are more intrusive may be due to concerns
about complications. In addition, we found that women
who were not married or in a common-law relationship
were more likely to report that they would not follow
recommendations for progesterone. Marriage may be a
proxy for social support [30] and less immediate social
support may impact decision making. Previous studies
have reported that women who are not married were
more likely to start prenatal care later and have fewer
prenatal visits [31] and in turn, women who receive less
prenatal care have been associated with lower self-
esteem and confidence [32]. Providing additional sup-
port or resources might be particularly important to this
group of women, hence suggesting reputable online in-
formation sources would likely be beneficial.
Strengths of our study include a diverse sample of
women from a broad range of healthcare providers
including obstetricians, midwives and family physi-
cians. Second, the response rate of our survey of
85.2% is robust, thus reducing the potential impact of
selection bias. Third, our questionnaire was piloted,
which likely increased read-ability. Finally, we used
previous surveys that studied the preferences and
values for PTB prevention to inform the design of
our questionnaire [15].
Limitations of our study include that most women
were relatively well educated, therefore, our results
can only be understood in this context. Women who
are more educated may prefer active participation in
medical decisions [33] and are less likely to rely solely
on the expertise of their healthcare providers for in-
formation. Further, because women in our sample
were at a median of 32 weeks of gestation, they may
prefer not to use PTB prevention because they were
in the third trimester, and unaware of the risks of
giving birth at this point in the pregnancy. Future
surveys should consider women earlier in their preg-
nancy. Second, most women who responded to our
survey were not at increased-risk for PTB.















Progesterone 309 1 (0.3) 1 (0.3) 7 (2.3) 8 (2.6) 292 (94.5)
Cerclage 306 2 (0.6) 2 (0.6) 4 (1.3) 9 (2.9) 289 (94.4)
Pessary 307 2 (0.6) 2 (0.6) 9 (2.9) 9 (2.9) 285 (92.8)
Potential Harm
Caused to Mother
Progesterone 309 4 (1.3) 6 (1.9) 20 (6.5) 86 (27.8) 193 (62.5)
Cerclage 306 5 (1.6) 5 (1.6) 14 (4.6) 60 (19.6) 222 (72.5)
Pessary 307 3 (1.0) 5 (1.6) 18 (5.9) 71 (23.1) 210 (68.4)
Effectiveness of
Prevention
Progesterone 309 1 (0.3) 4 (1.3) 29 (9.4) 67 (21.7) 239 (78.1)
Cerclage 306 2 (0.6) 3 (1.0) 22 (7.2) 40 (13.1) 239 (78.1)
Pessary 307 2 (0.6) 3 (1.0) 26 (8.5) 52 (16.9) 224 (73.0)
Associated
Financial Cost
Progesterone 309 92 (29.8) 38 (12.3) 75 (24.3) 65 (21.0) 39 (12.6)
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Hypothetical scenarios represent abstractions of real-
life phenomena and women who are not at increased
risk for PTB may answer differently if they were actu-
ally at increased risk. However, it is also possible that
because our questionnaire offers anonymity and confi-
dentiality, women may be more likely to answer their
actual preferences for PTB prevention. Previous stud-
ies have found that almost one-fifth of women using
progesterone to manage risk of PTB report issues of
compliance [17]. More research needs to be con-
ducted around patient compliance with treatment.
Conclusions
Our findings have implications for women’s prenatal
care. We found that most women preferred not to
use PTB prevention but still preferred close-
monitoring of their pregnancy if they were told by
their healthcare provider they were at increased risk
for PTB. A sizeable portion of women reported that
they would not follow their healthcare provider’s rec-
ommendations for cerclage and pessary, respectively,
hence, providing additional education to women re-
quiring such interventions would be particularly im-
portant. Since the complications of PTB can be
severe and long-lasting, it is important to provide
high quality education to women about PTB and the
benefits associated with PTB prevention, including
through websites as 70% of women in our survey re-
ported they would use the internet to learn more
about PTB prevention. Written or online information
could help supplement the education provided by
healthcare providers, which is important as a previ-
ous study had reported poor recall concordance be-
tween physicians and parents on key factors like
potential neonatal complications resulting from PTB
[34]. Further, because of the importance of health-
care providers influence on prenatal care, there is a
need to better understand the healthcare providers’
knowledge of, preferences for, and concerns about
PTB prevention.
Additional file
Additional file 1: Questionnaire adminstered to women to assess their
thoughts about and preferences for PTB prevention. (PDF 578 kb)
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Table 5 Multivariate logistic regression of the likelihood of not following healthcare provider’s recommendation
Variablesa Progesterone Cerclage Pessary
Multivariate
Analysis OR (95% CIs)
p-valueb Multivariate
Analysis OR (95% CIs)
p-valueb Multivariate
Analysis OR (95% CIs)
p-valueb
Pregnant Women’s Characteristics
European or White-Caucasian ethnicity
(self-reported)
0.41 (0.17, 1.01) 0.05
Not married or in common-law relationship 5.88 (1.72, 20.00) 0.0049
Preterm Birth Prevention Issuesc
Preference for no prevention 3.39 (1.93, 5.96) <0.0001 2.99 (1.51, 5.92) 0.002
Abbreviations: OR, odds ratio; CIs, confidence intervals. a“Preferred no prevention” included women who preferred no prevention or close-monitoring or were not
using a prevention if they were at increased risk for preterm birth; bSignificance was assessed using chi-squared test
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